SEPOY.net
No Result
View All Result
Saturday, June 14, 2025
  • Home
  • News
  • Business
  • Health
  • Tech
  • Lifestyle
  • Economy
  • Crypto
  • Travel
  • Home
  • News
  • Business
  • Health
  • Tech
  • Lifestyle
  • Economy
  • Crypto
  • Travel
No Result
View All Result
SEPOY.NET
No Result
View All Result
Home Health

PerkinElmer unveils industry-first cell analysis solution to streamline cell and gene therapy research and manufacturing

Nicholas by Nicholas
September 29, 2022
in Health
0

PerkinElmer, Inc., (NYSE: PKI), a global leader committed to innovating for a healthier world, today launched the Cellaca® PLX Image Cytometry System, a first-of-its-kind benchtop platform that enables researchers to assess multiple Critical Quality Attributes (CQAs) of cell samples in a single automated workflow, including cell identity, quality and quantity.

READ ALSO

SREBP identified as a central regulator of lipid metabolism and disease

Advancing precision oncology in intrahepatic cholangiocarcinoma

The cutting-edge Cellaca PLX system, designed by the company’s Nexcelom unit, combines best-in-class image cytometer hardware, software, validated consumables and trackable data reporting all in one system without requiring complex calibration procedures or intense training requirements. To further streamline the customer experience, optimized reagent kits with validated antibodies from PerkinElmer’s BioLegend business are also part of the proprietary solution.

The new offering provides researchers expanded cell sample CQA analysis options beyond flow cytometry and staining methods, which historically have required a variety of different instruments and analytical methods. By combining these capabilities, researchers can now detect multiple markers simultaneously (multiplexing) and perform immunophenotyping and viability assays in seconds with an easy-to-use, modern user interface.

Pharmaceutical companies have invested heavily in cell and gene therapy, but they struggle to assess the complex cell samples required to meet immense scientific demands and regulatory rigor across their research and manufacturing processes,”

Alan Fletcher, senior vice president, Life Sciences, PerkinElmer.

“While the Cellaca PLX Image Cytometer platform is therapeutic area agnostic, it is expected to be especially beneficial for researchers working in CAR-T cell therapy who want to streamline their phenotyping of immune cells for downstream processes.”

PerkinElmer’s Nexcelom unit is a leading provider of automated cell counting technology and image cytometry products for cell analysis, including the original and widely adopted Cellaca® MX high-throughput automated cell counter. Learn more about the new platform and other image cytometry instruments and reagents at BioProcessing International East from September 27-30 in Boston where PerkinElmer is showcasing the latest innovations across its extensive Life Science and cell and gene therapy portfolio in booths 625 and 631. Product demonstrations can be scheduled here.

About PerkinElmer

PerkinElmer is a leading, global provider of end-to-end solutions that help scientists, researchers and clinicians better diagnose disease, discover new and more personalized drugs, monitor the safety and quality of our food, and drive environmental and applied analysis excellence. With an 85-year legacy of advancing science and a mission of innovating for a healthier world, our dedicated team of more than 16,000 collaborates closely with commercial, government, academic and healthcare customers to deliver reagents, assays, instruments, automation, informatics and strategic services that accelerate workflows, deliver actionable insights and support improved decision making.

We are also deeply committed to good corporate citizenship through our dynamic ESG and sustainability programs. The Company reported revenues of approximately $5.0 billion in 2021, serves customers in 190 countries, and is a component of the S&P 500 index. Additional information is available at www.perkinelmer.com. Follow PerkinElmer on LinkedIn, Twitter, Facebook, Instagram, and YouTube.

Source

Tags: CellCytometerCytometryGeneGene TherapyManufacturingReagentsResearch

Related Posts

SREBP identified as a central regulator of lipid metabolism and disease
Health

SREBP identified as a central regulator of lipid metabolism and disease

June 14, 2025
Advancing precision oncology in intrahepatic cholangiocarcinoma
Health

Advancing precision oncology in intrahepatic cholangiocarcinoma

June 14, 2025
Boosting CAR T cell survival to improve solid tumor therapy
Health

Boosting CAR T cell survival to improve solid tumor therapy

June 13, 2025
UK study finds small proportion of early Alzheimer’s patients suitable for latest treatments
Health

UK study finds small proportion of early Alzheimer’s patients suitable for latest treatments

June 13, 2025
Kennedy’s HHS sent Congress ‘junk science’ to defend vaccine changes, experts say
Health

Kennedy’s HHS sent Congress ‘junk science’ to defend vaccine changes, experts say

June 13, 2025
Prenatal exposure to forever chemicals linked to higher teen blood pressure
Health

Prenatal exposure to forever chemicals linked to higher teen blood pressure

June 13, 2025
Next Post

Some Known Factual Statements About Hair Transplant

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

About

Sepoy.net is a perfect place for people who want daily updates on news related to business, technology, entertainment, health, cryptocurrency etc.

Contact: hello@sepoy.net

Major Categories

News

Business

Tech

Economy

 

Recent Posts

  • $5 Put Gambling enterprises NZ Totally Iron Man 3 Rtp real money free Revolves For five dollar
  • Der beste Online Spielbank Bonus exklusive Einzahlung 2025
  • Old Egypt Harbors Gamble casino Tomb Raider Rtp Egyptian-Themed Ports free of charge

Pages

  • About Us
  • Contact Us
  • Disclaimer
  • DMCA
  • Home
  • Privacy Policy

© 2023 Sepoy.net

No Result
View All Result
  • Home
  • Business
  • News
  • Health
  • Tech
  • Science
  • Lifestyle
  • Travel

© 2023 Sepoy.net